Exchange: NSE Sector: Healthcare Industry: Drug Manufacturers—General
-0.74% INR207.20
America/New_York / 8 mai 2024 @ 05:59
FUNDAMENTALS | |
---|---|
MarketCap: | 17 540 mill |
EPS: | 4.26 |
P/E: | 48.64 |
Earnings Date: | May 22, 2024 |
SharesOutstanding: | 84.65 mill |
Avg Daily Volume: | 1.055 mill |
RATING 2024-05-08 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Buy | |
Return On Asset: | Neutral | |
DE: | Sell | |
P/E: | Buy | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | n/a | n/a | n/a | |||
Debt | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 48.64 | sector: PE 0 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE 48.64 | industry: PE 0 |
DISCOUNTED CASH FLOW VALUE |
---|
INR-47.19 (-122.78%) INR-254.39 |
Date: 2024-05-08 |
Expected Trading Range (DAY) |
---|
INR 195.19 - 219.21 ( +/- 5.80%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | INR207.20 (-0.74% ) |
Volume | 0.285 mill |
Avg. Vol. | 1.055 mill |
% of Avg. Vol | 27.05 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.